IJNP Editorial Board: Meeting new challenges.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 1, doi. 10.1017/S1461145706007498
- By:
- Publication type:
- Article
Works matching IS 14611457 AND DT 2007 AND VI 10 AND IP 1
Results: 19
1
2
Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 149, doi. 10.1017/S1461145706007115
- By:
- Publication type:
- Article
3
Late occurrence of clozapine-associated polyserositis.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 147, doi. 10.1017/S1461145706006961
- By:
- Publication type:
- Article
4
Recent non-medication trials of interpersonal psychotherapy for depressionPresented in the session on Psychological Treatments Combined with Pharmacotherapy in the CINP Presidential Symposium at the Regional Meeting of the CINP, Brisbane, Australia, December 2005.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 117, doi. 10.1017/S1461145706006936
- By:
- Publication type:
- Article
5
What is the place of psychological treatments in mood disorders?Presented in the session on Psychological Treatments Combined with Pharmacotherapy in the CINP Presidential Symposium at the Regional Meeting of the CINP, Brisbane, Australia, December 2005.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 137, doi. 10.1017/S1461145706006924
- By:
- Publication type:
- Article
6
Cognitive therapy in relapse prevention in depressionPresented in the session on Psychological Treatments Combined with Pharmacotherapy in the CINP Presidential Symposium at the Regional Meeting of the CINP, Brisbane, Australia, December 2005.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 131, doi. 10.1017/S1461145706006912
- By:
- Publication type:
- Article
7
A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disordersPresented in the session on Psychological Treatments Combined with Pharmacotherapy in the CINP Presidential Symposium at the Regional Meeting of CINP, Brisbane, Australia, December 2005.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 123, doi. 10.1017/S1461145706006900
- By:
- Publication type:
- Article
8
Introduction to the Special Section: Integration of psychological treatments and pharmacotherapy in affective disorders.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 113, doi. 10.1017/S1461145706006894
- By:
- Publication type:
- Article
9
Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 3, doi. 10.1017/S1461145706006857
- By:
- Publication type:
- Article
10
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 7, doi. 10.1017/S1461145706006547
- By:
- Publication type:
- Article
11
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 107, doi. 10.1017/S1461145706006523
- By:
- Publication type:
- Article
12
Brain SPECT study of common ground between hypothyroidism and depression.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 99, doi. 10.1017/S1461145706006481
- By:
- Publication type:
- Article
13
Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 31, doi. 10.1017/S1461145705006462
- By:
- Publication type:
- Article
14
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 21, doi. 10.1017/S1461145705006425
- By:
- Publication type:
- Article
15
Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 51, doi. 10.1017/S1461145705006413
- By:
- Publication type:
- Article
16
Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 85, doi. 10.1017/S1461145705006401
- By:
- Publication type:
- Article
17
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 41, doi. 10.1017/S1461145705006395
- By:
- Publication type:
- Article
18
Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 63, doi. 10.1017/S1461145705006371
- By:
- Publication type:
- Article
19
Discontinuation symptoms in depression and anxiety disorders.
- Published in:
- International Journal of Neuropsychopharmacology, 2007, v. 10, n. 1, p. 73, doi. 10.1017/S1461145705006358
- By:
- Publication type:
- Article